174 related articles for article (PubMed ID: 31391495)
1. Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors.
Karkare S; Allen KJH; Jiao R; Malo ME; Dawicki W; Helal M; Godson DL; Dickinson R; MacDonald-Dickinson V; Yang R; Hoang B; Gorlick R; Geller DS; Dadachova E
Sci Rep; 2019 Aug; 9(1):11476. PubMed ID: 31391495
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).
Geller DS; Morris J; Revskaya E; Kahn M; Zhang W; Piperdi S; Park A; Koirala P; Guzik H; Hall C; Hoang B; Yang R; Roth M; Gill J; Gorlick R; Dadachova E
Nucl Med Biol; 2016 Dec; 43(12):812-817. PubMed ID: 27744117
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.
Broqueza J; Prabaharan CB; Allen KJH; Jiao R; Fisher DR; Dickinson R; MacDonald-Dickinson V; Uppalapati M; Dadachova E
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056067
[TBL] [Abstract][Full Text] [Related]
4. Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.
Boisclair C; Dickinson R; Giri S; Dadachova E; MacDonald-Dickinson V
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768202
[TBL] [Abstract][Full Text] [Related]
5. Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma.
Broqueza J; Prabaharan CB; Andrahennadi S; Allen KJH; Dickinson R; MacDonald-Dickinson V; Dadachova E; Uppalapati M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34064450
[TBL] [Abstract][Full Text] [Related]
6. Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).
Prabaharan CB; Giri S; Allen KJH; Bato KEM; Mercado TR; Malo ME; Carvalho JLC; Dadachova E; Uppalapati M
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570809
[TBL] [Abstract][Full Text] [Related]
7. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
8. Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.
Scott MC; Tomiyasu H; Garbe JR; Cornax I; Amaya C; O'Sullivan MG; Subramanian S; Bryan BA; Modiano JF
Dis Model Mech; 2016 Dec; 9(12):1435-1444. PubMed ID: 27874835
[TBL] [Abstract][Full Text] [Related]
9. Jaw osteosarcoma models in mice: first description.
Bertin H; Guilho R; Brion R; Amiaud J; Battaglia S; Moreau A; Brouchet-Gomez A; Longis J; Piot B; Heymann D; Corre P; Rédini F
J Transl Med; 2019 Feb; 17(1):56. PubMed ID: 30813941
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.
Canter RJ; Grossenbacher SK; Foltz JA; Sturgill IR; Park JS; Luna JI; Kent MS; Culp WTN; Chen M; Modiano JF; Monjazeb AM; Lee DA; Murphy WJ
J Immunother Cancer; 2017 Dec; 5(1):98. PubMed ID: 29254507
[TBL] [Abstract][Full Text] [Related]
11. Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma.
Fu Y; Yu J; Liatsou I; Du Y; Josefsson A; Nedrow JR; Rindt H; Bryan JN; Kraitchman DL; Sgouros G
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4382-4393. PubMed ID: 35809088
[TBL] [Abstract][Full Text] [Related]
12. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
13. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
14. Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma.
Giri S; Allen KJH; Prabaharan CB; Ramirez JB; Fiore L; Uppalapati M; Dadachova E
Nucl Med Biol; 2024 May; 134-135():108917. PubMed ID: 38718557
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of adenoviral vector-mediated p53 gene transfer on the growth of canine osteosarcoma xenografts in nude mice.
Kanaya N; Yazawa M; Goto-Koshino Y; Mochizuki M; Nishimura R; Ohno K; Sasaki N; Tsujimoto H
J Vet Med Sci; 2011 Jul; 73(7):877-83. PubMed ID: 21350316
[TBL] [Abstract][Full Text] [Related]
16. Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.
Cao JW; Lake J; Impastato R; Chow L; Perez L; Chubb L; Kurihara J; Verneris MR; Dow S
Cancer Immunol Immunother; 2024 Mar; 73(5):77. PubMed ID: 38554158
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer.
Jiao R; Allen KJH; Malo ME; Helal M; Jiang Z; Smart K; Buhl SV; Rickles D; Bryan RA; Dadachova E
Cancer Med; 2019 Sep; 8(11):5289-5300. PubMed ID: 31309741
[TBL] [Abstract][Full Text] [Related]
19. Canine and murine models of osteosarcoma.
Beck J; Ren L; Huang S; Berger E; Bardales K; Mannheimer J; Mazcko C; LeBlanc A
Vet Pathol; 2022 May; 59(3):399-414. PubMed ID: 35341404
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]